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ABSTRACT N-Methyl-D-aspartate (NMDA) receptors are susceptible to open-channel block by dizolcipine (MK-801),
ketamine and Mg2 and are permeable to Ca2. It is thought that a tryptophan residue in the second membrane-associated
domain (M2) may form part of the binding site for open-channel blockers and contribute to Ca2 permeability. We tested this
hypothesis using recombinant wild-type and mutant NMDA receptors expressed in HEK-293 cells. The tryptophan was
mutated to a leucine (W5L) in both the NMDAR1 and NMDAR2A subunits. MK-801 and ketamine progressively inhibited
currents evoked by glutamate, and the rate of inhibition was increased by the W5L mutation. An increase in open channel
probability accounted for the acceleration. Fluctuation analysis of the glutamate-evoked current revealed that the NMDAR1
W5L mutation increased channel mean open time, providing further evidence for an alteration in gating. However, the
equilibrium affinities of Mg2 and ketamine were largely unaffected by the W5L mutation, and Ca2 permeability was not
decreased. Therefore, the M2 tryptophan residue of the NMDA channel is not involved in Ca2 permeation or the binding of
open-channel blockers, but plays an important role in channel gating.
INTRODUCTION
Excitatory synaptic transmission in the central nervous sys-
tem is mediated primarily by ionotropic glutamate receptors
(iGluRs) (Collingridge and Lester, 1989). The iGluR family
is divided into several groups based on pharmacology. Re-
ceptors that are activated by N-methyl-D-aspartate (NMDA)
are permeable to Ca2 (Mayer and Westbrook, 1987;
Schneggenburger et al., 1993) and are blocked by Mg2 at
hyperpolarized membrane potentials (Mayer et al., 1984;
Kutsuwada et al., 1992). In contrast, most receptors acti-
vated by -amino-3-hydroxy-5-methyl-4-isoxazole propi-
onate (AMPA) or kainate are Ca2 impermeable (Iino et al.,
1990) and none are blocked by Mg2. These important
functional properties are determined by amino acid residues
at key locations in the M2 region, which is believed to line
the channel pore of iGluRs. One of these locations is termed
the “Q/R/N” site, because it is occupied by an asparagine
residue in NMDA receptors, and a glutamine or arginine in
non-NMDA receptors (Moriyoshi et al., 1991; Mori et al.,
1992; Burnashev et al., 1992a,b; Jonas and Burnashev,
1995). When the Q/R/N-site of an NMDA receptor is mu-
tated from an asparagine to a glutamine, Ca2 permeability
and open-channel block are reduced (Burnashev et al.,
1992b; Mori et al., 1992). When the opposite mutation is
applied to the Q/R/N site of a Ca2-permeable AMPA
receptor, changing the glutamine to an asparagine, Ca2
permeability is increased (Dingledine et al., 1992).
The divalent cation permeability of non-NMDA receptors
is also influenced by another site in the M2 region, five
residues toward the amino terminal from the Q/R/N site.
This is labeled the 5 position using a convention that
numbers the amino acid residues of iGluRs relative to the
Q/R/N site, with the amino-terminal direction being nega-
tive (Kuner et al., 1996). NMDA receptors have a trypto-
phan residue at the 5 position, while AMPA receptors
have a leucine. When the AMPA receptor GluR1 subunit
has the 5 leucine mutated to a tryptophan (L5W) it
becomes permeable to divalent cations, and susceptible to
block by the NMDA open-channel blocker, phencyclidine
(PCP) (Ferrer-Montiel et al., 1996). Sensitivity to PCP can
also be introduced by the Q0N mutation, but is greatly
increased by the additional L5W mutation. However, the
mutant channel remains insensitive to Mg2 block. When
the opposite mutation (W5L) is applied to the NMDAR2B
subunit, NMDA channels have a reduced sensitivity to
Mg2 block (Williams et al., 1998). The NMDAR2B W-8L
mutation also reduces sensitivity to Mg2 block, but the
same mutation of NMDAR2A has little effect (Williams et
al., 1998). The effects of the W5L mutation of the
NMDAR2A subunit have not yet been investigated. It also
remains to be determined whether the 5 site is involved in
Ca2 permeation and open-channel block of NMDA chan-
nels, as it is in AMPA channels.
The present study assessed the role of the 5 tryptophan
residue of NMDA receptors in calcium permeability and
open-channel block. NMDAR1 and NMDAR2A subunits
were coexpressed and the 5 tryptophan was mutated to
leucine (W5L), on either or both subunits. The mutation
altered channel gating and increased the rate of progressive
inhibition produced by MK-801 and ketamine. However,
the W5L mutation did not significantly affect the equilib-
rium affinity of open-channel blockers and had little effect
on Ca2 permeability.
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METHODS
Mutagenesis and plasmid preparation
Mouse cDNA clones of the NMDAR subunits NMDAR1 and NMDAR2A
were ligated into the mammalian expression vector pCDNA3() (Invitro-
gen, San Diego, CA). In this plasmid, an enhancer and the human cyto-
megalovirus promoter precede the cloning site. Mutations were introduced
using a Pfu-polymerase based double-stranded DNA site-directed mu-
tagenesis system (Quikchange, Stratagene, La Jolla, CA). The sequences of
all wild-type and mutant subunit cDNAs were confirmed using a dye-
terminator sequencing method (ABI Prism Big Dye, PE Applied Biosys-
tems, Rofkreuz, Switzerland). Plasmids for the transformation of HEK-293
cells were prepared by purification on a cesium chloride gradient or by
using an ion-exchange column based plasmid purification procedure (Jet-
star Maxipreps, Genomed, Bad Oeynhausen, Germany, and Qiagen Mega-
preps, Qiagen, Hilden, Germany).
Expression system
HEK-293 cells were grown to 80% confluence in MEM (Dulbecco’s
minimal essential medium supplemented with 10% fetal calf serum) and
harvested with trypsin. Harvested cultures were resuspended in BME
(Eagle’s basal medium supplemented with 10% fetal calf serum) and
placed in a 0.4-cm electroporation cuvette together with plasmid coding for
the CD4 cell surface antigen (0.5 g) and plasmid coding for NMDAR1
and NMDAR2A (5 g each). The cells were electroporated at 250 V using
a 960 F capacitance extender (Gene Pulser, BioRad, Hercules, CA),
which yielded pulse decay time constants of between 11.5 and 13.5 ms.
Cells were seeded onto 35-mm glass cover slips and incubated in BME
supplemented with the NMDA receptor antagonists D-AP5 (1 mM, Tocris)
and kynurenate (3 mM, Sigma) for between 12 and 24 h. BME was used
in preference to MEM because it contained a lower concentration of
glutamate. Preliminary studies revealed that when transfected cells were
maintained in MEM very few cells expressed NMDA channels, even when
supplemented with antagonist (data not shown). Cells expressing NMDA
receptors may have been killed by the excitotoxic effects of glutamate in
the MEM out-competing the antagonists. The cover slips were treated with
1.4  105 anti-CD4 beads (Dynabeads M-450 CD4 T-helper/inducer,
Dynal, Oslo, Norway) and placed on a platform rocker for 10 min.
Dynabeads preferentially adhered to transformed cells permitting them to
be identified for electrophysiological recording.
Solutions
The pipette solution contained 140 mM CsCl, 10 mM BAPTA, 10 mM
HEPES and was adjusted to pH 7.2 with CsOH and 285 mOsm with
glucose. All extracellular solutions contained 10 mM HEPES and were
adjusted to pH 7.2 and 285 mOsm. The extracellular solutions for the
ketamine and MK-801 inhibition experiments, and for the fluctuation
analysis study contained 150 mM NaCl and 1 mM CaCl2. The extracellular
solution for the Mg2 inhibition experiments contained 140 mM NaCl and
2 mM CaCl2. Mg
2 concentration was adjusted by mixing in a solution
containing 110 mM MgCl2. Calcium permeability was determined using
three different extracellular solutions containing 150 mM CsCl, 110 mM
CaCl2, 150 mM N-methyl-D-glucosamine (NMDG
). Different Ca2 con-
centrations were achieved by mixing these solutions in the appropriate
proportions. Where glutamate was added to the external solution to activate
NMDA receptors, glycine (10 M) was included as a co-agonist.
Electrophysiology
Recordings were made from HEK-293 cells in whole-cell or outside-out
patch configuration using an Axopatch 200A amplifier (Axon Instruments,
Foster City, CA). Cells were patched using 2–3 M pipettes pulled from
borosilicate hematocrit tubes. They were held at 60 mV unless otherwise
stated. Cells and patches were lifted away from the cover slips and
solutions were applied using a multi-barrel perfusion system. The solution
exchange time constant for HEK-293 cells was 39  5 ms (n  15) as
measured by the inhibition of NMDA currents with 150 mM Mg2 (Lester
et al., 1990). Current-voltage (I-V) curves were constructed by stepping the
membrane potential from 100 mV to 140 mV in 10-mV increments.
Leak currents were recorded before and after the agonist application. They
were averaged and subtracted offline.
Results were collected using AxoData (Axon Instruments, Foster City,
CA) or Chart 3.2 (AD Instruments, NSW, Australia) data acquisition
software. Current-voltage and fluctuation analysis data were sampled at 2
kHz and low-pass filtered at 1 kHz. MK-801 and ketamine data were
sampled at 4 Hz and low-pass filtered at 2 Hz. Analysis was performed off
line using AxoGraph (Axon Instruments, Foster City, CA). All results are
given as mean  SE. In the figures, error bars represent  SE and *
represents a significant difference based on one-way analysis of variance
(ANOVA, p  0.05), unless otherwise stated.
Fluctuation analysis
The steady-state currents recorded during a prolonged drug application was
converted to a power spectrum via a fast Fourier transform. The spectrum
was fit with the equation for a single Lorenzian equation (Mayer et al.,








S(f) is the power density at the frequency of f, S(0) is the zero frequency
asymptote and fc is the corner frequency at which S(f)  S(0)/2. The mean






The permeability properties of NMDA receptors do not follow the predic-
tions of the Goldmann-Hodgkin-Katz equation (Ascher and Nowak, 1988;
Wollmuth and Sakmann, 1998), even though the channels appear to have
an ionic occupancy of one under many recording conditions (Zarei and
Dani, 1994). This discrepancy arises because of ion-ion interactions at or
near the channel pore (Schneggenburger and Ascher, 1997; Premkumar
and Auerbach, 1996; Sharma and Stevens, 1996). We therefore used a
method for investigating Ca2 permeability that was designed to minimize
ion-ion interactions (Wollmuth and Sakmann, 1998).
To quantify the relative Ca2 permeability PCa2/PCs the difference
between the Ca2 and Cs solutions reversal potentials (Erev) was de-
termined. This value was substituted into a modified Lewis equation







Tip potentials offsets were measured and used to correct the observed
reversal potentials. For simplicity, and to allow a direct comparison with
other results using this method (Wollmuth and Sakmann, 1998), calcula-
tions were based on concentrations without correction for activity coeffi-
cients. Under our recording conditions, activity coefficients show negligi-
ble variation with Ca2 concentration, and their inclusion in the calculation
would approximately double the permeability ratio at all concentrations
(data not shown).
NMDA Gating Influenced by a Tryptophan in M2 2455
Biophysical Journal 79(5) 2454–2462
Estimation of the IC50 for Mg
2 block
Dose-inhibition curves were recorded at a holding potential of 100 mV









where IMg2 is the normalized current at 100 mV, IC50 is the Mg
2




Currents were evoked in HEK-293 cells expressing NMDA
receptors by applying glutamate (1 mM). When the evoked
current had reached steady-state (10 s), a rapid step (ex-
change time constant 40 ms) was made into a solution
containing both MK-801 (1 M) and glutamate. The current
was progressively inhibited with a time course that had
distinct fast (0.3 s) and slow (10 s) components (Fig. 1
A). Theory and modeling suggest that the fast component of
MK-801 inhibition is due to a rapid reduction in the MOT
of NMDA channels, while the slow component is due to
progressive elimination of the channels as they are irrevers-
ibly blocked by MK-801 (Rosenmund et al., 1993). The
relative magnitude of the fast block is determined by the
MOT of the channels in the absence of MK-801, and by the
binding rate of MK-801 to open channels. The time constant
of the slow progressive inhibition is not sensitive to the
MOT, but is determined by the open probability of the
FIGURE 1 Fast and slow components of inhibi-
tion by MK-801 (1 M) of whole-cell NMDA
currents. (A) The slow, progressive inhibition was
fit with a single exponential. Fast block was defined
as the difference between the steady-state current
amplitude immediately before MK-801 application,
and the amplitude of the fitted exponential imme-
diately after MK-801 application. Exponential fits
to the fast component of the inhibition had time
constants of less than 0.3 s (data not shown), which
is consistent with the solution exchange rate in this
system. (B) The fast block was increased signifi-
cantly by the NMDAR1 W5L mutation, but not
by the NMDAR2A W5L mutation or the double
mutation (n  8). (C) Noise analysis of whole-cell
NMDA current. The power spectrum recorded in
the absence of glutamate was subtracted from the
spectrum recorded in glutamate (1 mM). The spec-
trum was fit with a Lorenzian equation to estimate
the channel mean open time. (D) The MOT was
significantly increased by the NMDAR1 W5L
mutation, but not by the NMDAR2A W5L muta-
tion or the double mutation (n  6).
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NMDA channel, and also by the binding rate of MK-801
(Rosenmund et al., 1993). The fast component of the MK-
801 block reduced the steady-state NMDA current by 23 
2% (n  8) in wild-type receptors. The magnitude of the
fast block was approximately doubled by the NMDAR1
W5L mutation to 47  4% (n  8) (Fig. 1 B). In contrast,
the NMDAR2A W5L mutation had no effect on the fast
block. Surprisingly, when both subunits contained the mu-
tation the fast block was not significantly altered (Fig. 1 B).
The enhancement of the fast block of NMDAR1 W5L
channels by MK-801 may be due to an increased MOT, or
to a faster MK-801 binding rate to open channels, or both.
To distinguish between these possibilities, we estimated the
MOT using fluctuation analysis of steady-state NMDA cur-
rents (Mayer et al., 1988). A current was evoked by pro-
longed application of glutamate (1 mM, 250 s). The power
spectrum of the noise in the absence of agonist was sub-
tracted from the power spectrum of the evoked steady-state
current. A single Lorenzian equation was optimally fit to the
difference spectrum (Fig. 1 C). The corner frequency for the
result shown in Fig. 1 C was 80 Hz, which was typical for
wild-type NMDA receptors. The MOT for these receptors
(from Eq. 2) was 2  0.1 ms (n  8). This is comparable to
the MOT value of 4 ms obtained for native NMDA recep-
tors from cultured neurons using the fluctuation analysis
technique (Mayer et al., 1988), and a value of 3 ms obtained
from single-channel recordings (Stern et al., 1994). The
NMDAR1 W5L mutation approximately doubled the
channel MOT to 4  0.1 ms (n  5) (Fig. 1 D). The
similarity between the increase in MOT, and the increase in
the magnitude of the fast MK-801 block (Fig. 1B, D)
suggests that the NMDAR1 W5L mutation alters channel
gating, but has little effect on the binding rate of MK-801 to
open channels. Neither the NMDAR2A W5L mutation
nor the double mutation had a detectable effect on the
channel’s MOT or on the fast MK-801 block. Together,
these data suggest that the 5 tryptophan is not directly
involved in forming the MK-801 binding site in the NMDA
channel, but it does have an important role in channel
gating. This hypothesis was further investigated by analyz-
ing the time course of the progressive inhibition in MK-801.
The slow component of MK-801 progressive inhibition
was fit with a single-exponential equation (Fig. 1 A), and the
time constant was 48  10 s (n  10) for wild-type NMDA
receptors. The time constant was approximately 3 times
faster at 14  2 s (n  7) for channels containing the
NMDAR1 W5L mutant subunit (Fig. 2 A). The acceler-
ation of the progressive inhibition must be due to an in-
crease in the open probability of the channel. The only
alternative explanation would be an increase in the binding
rate of MK-801 to open channels, but the results presented
in the previous paragraph rule out this possibility. The
increase in the open probability of channels containing the
NMDAR1 W5L subunit can be largely attributed to their
longer MOT (Fig. 1 D). Channels containing the
NMDAR2A W5L subunit were inhibited more rapidly by
MK-801, but the decrease in time constant was not signif-
icant. When the W5L mutation was present in both sub-
units, the time constant of inhibition was 21 4 s (n 12),
a significant decrease compared with the wild-type channels
(Fig. 2 A). In summary, NMDA receptors containing a
W5L mutation in either or both subunits generally exhib-
ited an increase in their MOT and open probability.
Another way to test for alteration of the binding site for
an open-channel blocker is to examine the rate of recovery
from inhibition. Following wash out of MK-801 in the
continued presence of glutamate, wild-type NMDA chan-
nels did not recover from block (data not shown). This is
consistent with previous results for native NMDA channels
where MK-801 block is irreversible on the time scale of
several minutes (Rosenmund et al., 1993). In contrast, MK-
801 unbound from NMDAR1 W5L and NMDAR2A
FIGURE 2 Time course of progressive inhibition by
MK-801 and recovery from inhibition. (A) The time con-
stant of the slow, progressive component of MK-801 inhi-
bition. The W5L mutation decreased the time constant of
inhibition, but the decrease was not significant for
NMDAR2A W5L receptors (n  6). (B) MK-801 can
unbind from NMDAR1 W5L and NMDAR2A W5L
receptors on the time scale of several minutes. In contrast,
the MK-801 block of wild-type receptors is irreversible on
this time scale (data not shown).
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W5L receptors on this time scale. One possible interpre-
tation is that the increased unbinding rate reflects increased
open-channel probability. It was difficult to reliably esti-
mate the unbinding rates due to rundown of the NMDA
response on this long time scale. To overcome this problem,
we studied the kinetic properties of the open-channel
blocker, ketamine, which is known to dissociate from wild-
type NMDA receptors much more rapidly than MK-801.
We first examined the inhibition rates and compared these
with the MK-801 results, then measured the recovery from
ketamine inhibition.
Ketamine block
NMDA receptor-mediated currents were evoked by gluta-
mate, and then a rapid step was made into a solution
containing both ketamine (10 M) and glutamate (Fig. 3 A).
The current was inhibited with a time course that had
distinct fast (0.3 s) and slow (4 s) components (Fig. 3
A). The time constant of the slow component was 9  2 s
(n  16) for the wild-type receptor, and this was reduced to
4  1 s (n  11) by the NMDAR1 W5L mutation (Fig.
3 B). This is consistent with the MK-801 results, and supports
the suggestion that NMDA channel open probability is in-
creased by the W5L mutation. Channels containing the
NMDAR2 W5L subunit appeared to be inhibited more rap-
idly by ketamine, but the rate increase was not significant.
Channels with the W5L mutation on both subunits were
inhibited by ketamine with a time constant of 2  0.4 s (n 
11), which was significantly faster than for the wild-type
FIGURE 3 Time course of progressive inhibition by
ketamine and recovery from inhibition. (A) The cur-
rent evoked by glutamate (1 mM) in wild-type NMDA
receptors was inhibited by ketamine (10 M). The
slow component of the inhibition, and the recovery
from inhibition were both fit with an exponential equa-
tion. (B) The time constants of progressive inhibition
in ketamine for wild-type and mutant NMDA recep-
tors. The W5L mutation decreased the time constant
of inhibition, but the decrease was not significant for
NMDAR2A W5L receptors (n  6). (C) The time
constants for recovery from ketamine inhibition. The
ketamine dissociation rate was significantly increased
when both subunits contained the W5L mutation
(n  6).
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receptors (Fig. 3 B). These results confirm that the W5L
mutation increases NMDA channel open probability.
Following the rapid removal of ketamine, the response
recovered as ketamine unbound from the NMDA channels
(Fig. 3 A). The recovery time constant is determined by the
dissociation rate of ketamine. For wild-type receptors, the
current recovered with a time constant of 10 1 s (n 21).
Introducing the W5L mutation to both NMDAR1 and
NMDAR2 reduced the recovery time constant (Fig. 3 C).
The ketamine dissociation rate was approximately doubled
in these channels. The recovery time constant appeared to
be reduced when the mutation was introduced to either
subunit alone, but the reduction was not significant. It has
been suggested that open-channel blockers become trapped
when the channel enters its closed state, and can only
dissociate when the channel is in the open state (Benveniste
and Mayer, 1995). If this is true for ketamine, then the faster
dissociation rate from channels carrying the W5L mutation
may simply reflect the increased open probability of these
channels. In this case, the faster dissociation rate would be
coupled with a faster binding rate, and no overall change in the
steady-state affinity of ketamine would be expected.
The affinity of ketamine at its binding site in the NMDA
channel pore was studied by measuring the equilibrium inhi-
bition of the glutamate-evoked current during a 60 s applica-
tion of ketamine (1 M) (Fig. 4 A). There was no significant
FIGURE 4 Equilibrium inhibition by ketamine. (A)
The current evoked by glutamate (1 mM) in wild-type
NMDA receptors was inhibited by ketamine (1 or 10
M). Ketamine was applied for 60 s, and the steady-
state current was measured when the inhibition had
reached equilibrium. (B) The residual current at equi-
librium was calculated as a fraction of the steady-state
current immediately before the application of ketamine.
The W5L mutation had no significant effect on the
equilibrium inhibition produced by ketamine (ANOVA,
n  5).
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difference between the equilibrium inhibition of wild-type
channels and channels containing the W5L mutation on one
or both subunits (Fig. 4B). These results support the suggestion
that the 5 residue does not form part of the binding site for
open-channel blockers. This leads to the prediction that the
W5L mutation will have little effect on the affinity with
which Mg2 inhibits the NMDA channel, because Mg2 com-
petes with MK-801 for a binding site in the channel pore
(Huettner and Bean, 1988).
Mg2 block
NMDA receptor-mediated currents were evoked in HEK-
293 cells and Mg2 was applied at a range of concentra-
tions. Cells were clamped at 100 mV to enhance the
voltage-dependent Mg2 block. A dose-inhibition plot was
constructed, and the IC50 was calculated by fitting a Hill
equation to the plot (Fig. 5 A). For the wild-type receptor,
the IC50 was 9.6  0.9 M (n  17), which is consistent
with the value obtained in other studies using recombinant
NMDA receptors (Burnashev et al., 1992a,b). As predicted,
the IC50 for Mg
2 was similar for the NMDAR1 W5L.
However, the NMDAR2A W5L mutation produced a
small but significant increase in IC50 to 26 3 M (n 21)
(Fig. 5 B). This effect was much smaller than the 20-fold
increase in the IC50 for Mg
2 produced by the NMDAR2A
N0Q mutation (Burnashev et al., 1992b), but very similar to
the increase recorded for the NMDAR2B W5L mutation
(Williams et al., 1998).
These results confirm that the 5 residue plays little or
no role in forming the binding site for open-channel block-
ers, contrary to previous suggestions (Ferrer-Montiel et al.,
1996). It has also been suggested previously that the 5
residue is involved in Ca2 permeation of AMPA and
NMDA channels. We next studied the Ca2 permeability of
wild-type and mutant NMDA receptors.
Ca2 permeability
The reversal potential of the glutamate-evoked currents was
recorded in a range of different solutions containing either
Ca2 or Cs as the only permeable ion (Fig. 6 A). The
impermeable organic cation N-methyl-D-glucosamine
(NMDG) was used to maintain the ionic strength of the
solutions. The difference between the reversal potential in
Cs and Ca2, Erev (Fig. 6 C), was plotted as a function of
Ca2 concentration (Fig. 6 B). This experimental approach
was used because it minimizes the number of ion-ion inter-
actions in and near the channel pore. The Lewis equation
was used to estimate the relative Ca2 permeability at each
Ca2 concentration (Wollmuth and Sakmann, 1998) (Fig.
6C). The Ca2 permeability was dependent on the Ca2
concentration, with a maximum at 1 mM for wild-type
receptors. This is consistent with the previous finding of a
permeability maximum at 0.8–1.0 mM Ca2 (Wollmuth
and Sakmann, 1998). Note that if the activity coefficients of
Ca2 and Cs had been taken into account, the values
calculated for the Ca2/Cs permeability ratio would be
approximately doubled (see Methods). At most Ca2 con-
centrations, there was no difference between the Ca2 per-
meability of wild-type receptors or receptors containing the
W5L mutation. A small increase in the relative perme-
ability for Ca2 was seen at 0.35 mM for NMDAR1 W5L
channels (Fig. 6 C) but was not statistically significant.
These results demonstrate that the 5 tryptophan residue
does not confer Ca2 permeability to NMDA receptors, as
had previously been suggested (Ferrer-Montiel et al., 1996).
FIGURE 5 Mg2 block. (A) Normalized whole-
cell current evoked by glutamate at 100 mV
plotted against Mg2 concentration (n  6). The
Hill equation was fit to the data (solid line) giving
an estimate IC50 for Mg
2. (B) The IC50 for Mg
2
was increased in receptors containing the
NMDAR2A W5L subunit (n  17).
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DISCUSSION
Recombinant NMDA receptors containing a W5L muta-
tion in either or both subunits exhibited an increased open
channel probability, but little or no change in their perme-
ability to divalent cations, or in the efficacy of open-channel
blockers. These results rule out any major role for the 5
tryptophan residue in enabling or facilitating divalent ion
permeation of NMDA channels. The 5 position was a
strong candidate for such a role because the L5W mutation
of the GluR1 subunit confers divalent cation permeability to
AMPA receptors (Ferrer-Montiel et al., 1996). The L5W
mutation also confers sensitivity to block by PCP, which
suggests that the 5 site may form part of the binding site for
NMDA receptor open-channel blockers. However, the results
of the present study are not consistent with such a role. Instead
they are consistent with the results of a cysteine scanning
mutagenesis study of NMDA receptors, which suggested that
the 5 position is not directly exposed to the channel pore
(Kuner et al., 1996; Beck et al., 1999).
The major effect of the NMDAR1 W5L mutation was
on channel gating. An increase in the open probability of
channels carrying the mutation can account for the in-
creased rates of progressive inhibition in the presence of
MK-801 or ketamine. A parallel increase in the MOT of the
mutant channels supports this interpretation. In contrast, a
change in the binding rate for these blockers is unlikely
because the change in the magnitude of the fast MK-801
block could be entirely attributed to the change in MOT. An
increased open probability could also explain the faster
dissociation of ketamine from channels carrying the W5L
mutation. This interpretation relies on the assumption that
ketamine is trapped when the channel is in the closed state
(Benveniste and Mayer, 1995). A stabilization of the open
state of the NMDAR1 W5L mutant channel could explain
the increase in their MOT and open probability.
Channels carrying the W5L mutation on the NMDAR1
subunit had an increased MOT, but channels carrying the
mutation on the NMDAR2A subunit were not affected.
When channels carried the mutation in both subunits, this
unexpectedly appeared to nullify the effect induced by the
mutation in NMDAR1 alone (Fig. 1). In contrast, when
other channel properties were examined, this nullifying
effect was not seen (Fig. 2, 3, and 5). Several interpretations
of these results are possible. For example, the changes in
channel properties produced by the W5L mutation might
have been simpler and more consistent than our data suggests,
but some changes were not detected at the p  0.05 level due
to experimental uncertainties. Alternatively, our data may ac-
curately reflect a complex pattern of alterations in channel
properties that arises from subunit-subunit interactions.
Ketamine was used to explore the affinity of the open-
channel block site of wild-type and mutant NMDA chan-
nels. It is more suitable than MK-801 for this purpose because
it dissociates on the time scale of several seconds from wild-
type channels. The W5L mutation produced no significant
change in the equilibrium block by ketamine. The progressive
inhibition in the presence of ketamine and the recovery fol-
lowing its removal, were both accelerated to a similar extent by
the mutation. Although these results do not rule out an alter-
ation of the ketamine binding site, they are most simply ex-
plained by an increase in open channel probability.
FIGURE 6 Relative Ca2 permeability. (A) The current-voltage rela-
tionship for wild-type NMDA receptors recorded in 0.35 mM Ca2 with no
added Cs (open circles), and in 143.5 mM Cs with no added Ca2 (open
squares). In all Ca2 solutions, ionic strength was maintained with
NMDG. The difference was measured between the reversal potentials in
these two solutions (Erev). (B) The value of Erev observed at a range of
different Ca2 concentrations for wild-type NMDA receptors (circles),
NMDAR1 W5L (diamonds), NMDAR2A W5L (squares), and double
mutant (triangles) (n  6). For some data points, the error bars are
obscured by the symbols. (C) Erev was used to calculate the relative
permeability to Ca2 at a range of different Ca2 concentrations. There
was no difference between the permeability of wild-type and mutant
channels (two-way ANOVA, p  0.05).
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The 2-fold decrease in the Mg2 affinity produced by the
W5L mutation of the NMDAR2A subunit was an order of
magnitude smaller than the decrease produced by the N0Q
mutation (Burnashev et al., 1992b). Interestingly, the effect
of these mutations on Mg2 block was confined to the 2A
subunit. These results suggest that the 5 tryptophan resi-
due influences the Mg2 binding site indirectly, possibly by
altering the position of key residues such as 0 asparagine.
It has been suggested that the 5 tryptophan residue
contributes to the Ca2 permeability of NMDA channels.
This hypothesis predicts that channels carrying the W5L
mutation should have a reduced Ca2 permeability. How-
ever, the mutation did not reduce Ca2 permeability at any
of the Ca2 concentrations tested in this study, suggesting
that the site is not directly involved in Ca2 permeation of
the channel. The mutation appeared to produced an increase
in permeability at 0.35 mM Ca2 but the change was not
significant (ANOVA, p  0.05).
In summary, NMDA receptors containing a W5L mu-
tation in either or both subunits generally exhibited an
increased open channel probability, but little or no change in
their permeability to divalent cations, or in the efficacy of
open-channel blockers. These results suggest that the 5
tryptophan residue has little influence on divalent ion per-
meation and open-channel block, but does play a significant
role in channel gating.
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